Management of Acute Decompensated Heart Failure

This module is part of the Advanced Critical Care Therapeutics Series.

Sign up today to access in-depth instruction concerning the pharmacotherapeutic management of decompensated heart failure. Didactic knowledge of the pathophysiology, pharmacology and drug therapy management on this topic will be provided. Emphasis is placed on the efficacy, safety and comparative value of drug therapy in this highly specialized practice area. Following completion of this CE topic, participants will have the most up-to-date information concerning the management of decompensated heart failure.

Presented By:  Daniel E. Hilleman, PharmD, FCCP

Objectives

• Describe the classification of decompensated heart failure based on hemodynamic patterns and clinical classification
• Describe the goals and general principles of management of decompensated heart failure
• Identify the most commonly used diuretics, vasodilators, and inotropes in the management of decompensated heart failure
• Identify treatments that either are not beneficial or that worsen decompensated heart failure
• Describe the use of non-pharmacologic device therapy in patients with medically refractory decompensated heart failure
   

Education Credit

Category 1
Creighton University Health Sciences Continuing Education designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAPA accepts AMA category 1 credit for the PRA from organizations accredited by ACCME.

Nurse CE
Creighton University Health Sciences Continuing Education designates this activity for 2.0 contact hours for nurses. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacy
Creighton University Health Sciences Continuing Education (HSCE) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education (CPE). This enduring material, Decompensated Heart Failure/Cardiogenic Shock, is accredited for 2.0 hour(s) for completion of all CE sessions.  Term of approval is from this date on August 22, 2020 until August 21, 2023.  The Advanced Critical Care Therapeutics is a knowledge-based CE activity.

Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Creighton University Health Sciences Continuing Education. Creighton University Health Sciences Continuing Education (HSCE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.